Endothelial progenitor cells (EPCs) are applied in the treatment of ischemic diseases. In ex vivo culture of human cord-blood derived EPCs, H1152, (S)-(+)-2-methyl-1-[(4-methyl-5-iso-quinolinyl) sulfonyl]-homopiperazine, markedly increased the number of EPCs. It also induced EPC migration, stimulated the phosphorylation of AKT, and reduced the expression of p27 in the EPCs. Thus H1152 can be used effectively in ex vivo expansion of EPCs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1271/bbb.110468 | DOI Listing |
Publication Analysis
Top Keywords
endothelial progenitor
8
epcs h1152
8
epcs
5
enhancement endothelial
4
progenitor cell
4
cell numbers
4
numbers migration
4
migration h1152
4
h1152 rho
4
rho kinase
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!